Foundations of Cancer Therapeutics (FCT), Commercialization – August 17-21, 2026, 10am-4pm
Register Here
We invite you to join us virtually to audit this year’s Foundations of Cancer Therapeutics Crash Course, August 17–21, focused on the commercialization aspects of moving therapeutics toward the market. Although cancer therapeutics will be highlighted, many concepts will apply broadly across therapeutic areas. This free webinar will introduce key topics including evaluating disease need, target populations and markets; lead assessment; intellectual property and licensing strategy; biotech formation versus out-licensing; funding strategies; preclinical and IND-enabling studies; clinical trials; regulatory strategy; and the Houston therapeutics landscape. The course will also highlight career paths that support therapeutic commercialization, including roles in technology transfer, investment, preclinical development, regulatory affairs, clinical trials, and commercialization strategy. Afternoon sessions will include examples of how AI and advanced computation can be leveraged across therapeutic development and commercialization. Confirmed speakers include: Suzanne Tomlinson-Mathis, IBT; Verena Valkhoff, Greater Houston Partnership; Reid Powell, Inst. of Biosciences and Technology; Ashley Jennings, GCC REACH; Uffaf Khan, Inst. of Biosciences and Technology; Andy Bader, TMC Innovation; Chanelle Mack, Univ. of Houston; Huan Xie, Texas Southern Univ.; Cliff Stephan, Inst. of Biosciences and Technology; Jeff Larson, Tvardi Therapeutics; Nassim Beiranvand, TMC Innovation; Diana Chow, Univ. of Houston; and Dong Liang, Texas Southern Univ.


